Correlation Between Silo Pharma and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Silo Pharma and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silo Pharma and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Silo Pharma and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Silo Pharma and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silo Pharma with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silo Pharma and Mineralys Therapeutics,.
Diversification Opportunities for Silo Pharma and Mineralys Therapeutics,
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Silo and Mineralys is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Silo Pharma and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Silo Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silo Pharma are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Silo Pharma i.e., Silo Pharma and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Silo Pharma and Mineralys Therapeutics,
Given the investment horizon of 90 days Silo Pharma is expected to under-perform the Mineralys Therapeutics,. But the otc stock apears to be less risky and, when comparing its historical volatility, Silo Pharma is 1.04 times less risky than Mineralys Therapeutics,. The otc stock trades about -0.27 of its potential returns per unit of risk. The Mineralys Therapeutics, Common is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 1,389 in Mineralys Therapeutics, Common on August 28, 2024 and sell it today you would lose (119.00) from holding Mineralys Therapeutics, Common or give up 8.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Silo Pharma vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Silo Pharma |
| Mineralys Therapeutics, |
Silo Pharma and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Silo Pharma and Mineralys Therapeutics,
The main advantage of trading using opposite Silo Pharma and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silo Pharma position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Silo Pharma vs. Rezolute | Silo Pharma vs. Lumos Pharma | Silo Pharma vs. Anebulo Pharmaceuticals | Silo Pharma vs. Sino Biopharmaceutical Limited |
| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |